Compounds > cytidine
Page last updated: 2024-08-17

cytidine and ribavirin

cytidine has been researched along with ribavirin in 24 studies

Research

Studies (24)

TimeframeStudies, this research(%)All Research%
pre-19902 (8.33)18.7374
1990's4 (16.67)18.2507
2000's8 (33.33)29.6817
2010's7 (29.17)24.3611
2020's3 (12.50)2.80

Authors

AuthorsStudies
Bernaerts, R; De Clercq, E; Montgomery, JA; Shealy, YF1
De Clercq, E; Marquez, VE; Murase, J1
De Clercq, E; Kitaoka, S; Konno, T1
De Clercq, E; Kawana, F; Shigeta, S1
Asawa, S; Konno, K; Shigeta, S; Sudo, K; Watanabe, W; Yokota, T1
Ijichi, K; Inoue, H; Konno, K; Shigeta, S; Watanabe, W; Yokota, T1
Morrey, JD; Sidwell, RW; Smee, DF; Tseng, C1
Breadmore, MC; Theurillat, R; Thormann, W1
Bartenschlager, R; Coelmont, L; De Clercq, E; Neyts, J; Paeshuyse, J; Windisch, MP1
Bu, W; Dadgostari, S; Lin, CC; Nguyen, M; Yeh, LT1
Chan, A; Everson, GT; Fried, MW; Ghalib, R; Godofsky, E; Harrison, S; Hill, G; Najera, I; Nelson, D; Nyberg, L; Pockros, PJ; Rodriguez-Torres, M; Shiffman, ML1
Bassit, L; Bennett, M; Grier, J; Schinazi, RF1
Elazar, M; Glenn, JS; Korba, BE; Lui, P; Rossignol, JF1
Kronenberger, B; Zeuzem, S1
Barclay, L; Costantini, VP; Lee, D; McBrayer, TR; Schinazi, RF; Vinjé, J; Whitaker, T1
Costa, I; Cunha, R; Dallmeier, K; Jochmans, D; Leyssen, P; Nascimento, MS; Neyts, J; Rocha-Pereira, J1
Feigelstock, DA; Mihalik, KB1
De Clercq, K; De Vleeschauwer, AR; Goris, N; Kollanur, D; Lefebvre, DJ; Murao, LE; Neyts, J; Osiceanu, AM; Swinnen, J1
Pan, Q; Peppelenbosch, MP; Qu, C; Wang, W; Xu, L; Yin, Y1
Crossman, DK; Crowley, MR; Frolov, I; Frolova, EI; Guthrie, DB; Kolykhalov, AA; Kuznetsova, V; Lockwood, MA; Natchus, MG; Painter, GR; Sokratian, A; Urakova, N1
Li, R; Li, S; Li, Y; Liao, A; Liu, B; Liu, Y; Lu, A; Wang, Q; Wang, Y; Wang, Z; Yu, J; Zhao, B1
Govil, A; Luckett, K; Miller-Handley, H1
Hughes, C; Lewis, P; Warren, S; Waters, MD; Zhang, F1
Bearne, SL; Gillis, TD1

Reviews

3 review(s) available for cytidine and ribavirin

ArticleYear
Future treatment options for HCV: double, triple, what is the optimal combination?
    Best practice & research. Clinical gastroenterology, 2008, Volume: 22, Issue:6

    Topics: Antiviral Agents; Cytidine; DNA-Directed RNA Polymerases; Drug Delivery Systems; Drug Resistance, Viral; Drug Therapy, Combination; Forecasting; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Nucleosides; Oligopeptides; Polyethylene Glycols; Prodrugs; Proline; Protease Inhibitors; Pyrimidine Nucleosides; Recombinant Proteins; Ribavirin

2008
Treatment Options for Coronavirus Disease 2019 in Patients With Reduced or Absent Kidney Function.
    Advances in chronic kidney disease, 2020, Volume: 27, Issue:5

    Topics: Adenosine Monophosphate; Alanine; Amides; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antiviral Agents; Chloroquine; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; COVID-19 Vaccines; Creatinine; Cytidine; Dexamethasone; Drug Combinations; Drug Interactions; Humans; Hydroxychloroquine; Hydroxylamines; Immunization, Passive; Interferons; Janus Kinase Inhibitors; Lopinavir; Pyrazines; Renal Elimination; Renal Insufficiency, Chronic; Renal Replacement Therapy; Ribavirin; Ritonavir; SARS-CoV-2

2020
Human genetic risk of treatment with antiviral nucleoside analog drugs that induce lethal mutagenesis: The special case of molnupiravir.
    Environmental and molecular mutagenesis, 2022, Volume: 63, Issue:1

    Topics: Amides; Antiviral Agents; COVID-19 Drug Treatment; Cytidine; Deoxyuridine; DNA Damage; Genome, Human; Humans; Hydroxylamines; Mutagenesis; Nucleosides; Pyrazines; Ribavirin; SARS-CoV-2

2022

Trials

1 trial(s) available for cytidine and ribavirin

ArticleYear
R1626 plus peginterferon Alfa-2a provides potent suppression of hepatitis C virus RNA and significant antiviral synergy in combination with ribavirin.
    Hepatology (Baltimore, Md.), 2008, Volume: 48, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Antiviral Agents; Cytidine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Resistance, Viral; Drug Synergism; Drug Therapy, Combination; Female; Hepacivirus; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Neutropenia; Nucleosides; Polyethylene Glycols; Prodrugs; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome; Viral Load

2008

Other Studies

20 other study(ies) available for cytidine and ribavirin

ArticleYear
Broad-spectrum antiviral activity of carbodine, the carbocyclic analogue of cytidine.
    Biochemical pharmacology, 1990, Jan-15, Volume: 39, Issue:2

    Topics: Animals; Antiviral Agents; Cell Line; Cell Survival; Cytidine; DNA; DNA Viruses; HeLa Cells; Humans; Microbial Sensitivity Tests; Nucleosides; Ribavirin; RNA; RNA Viruses; Tubercidin; Vero Cells; Virus Replication

1990
Broad-spectrum antiviral and cytocidal activity of cyclopentenylcytosine, a carbocyclic nucleoside targeted at CTP synthetase.
    Biochemical pharmacology, 1991, Jun-15, Volume: 41, Issue:12

    Topics: Adenosine; Amides; Antiviral Agents; Azauridine; Carbon-Nitrogen Ligases; Cell Division; Cytarabine; Cytidine; Deoxycytidine; Drug Synergism; Fluorouracil; HeLa Cells; Humans; Ligases; Nucleosides; Pyrazoles; Ribavirin; Ribonucleosides; Ribose; Thymidine; Tumor Cells, Cultured; Uracil; Virus Replication; Viruses

1991
Comparative efficacy of broad-spectrum antiviral agents as inhibitors of rotavirus replication in vitro.
    Antiviral research, 1986, Volume: 6, Issue:1

    Topics: Adenine; Adenosine; Amides; Antiviral Agents; Cell Line; Cytidine; Dose-Response Relationship, Drug; Pyrazoles; Ribavirin; Ribonucleosides; Ribose; Rotavirus; Tubercidin; Vidarabine; Virus Replication

1986
Inhibitory effects of several antiviral compounds on the replication of respiratory syncytial virus in vitro.
    Antiviral research, 1985, Volume: Suppl 1

    Topics: Amides; Antiviral Agents; Cytidine; Dose-Response Relationship, Drug; Guanine; HeLa Cells; Humans; Pyrazoles; Respiratory Syncytial Viruses; Ribavirin; Ribonucleosides; Ribose; Tubercidin; Virus Replication

1985
Use of lactate dehydrogenase to evaluate the anti-viral activity against influenza A virus.
    Journal of virological methods, 1995, Volume: 51, Issue:2-3

    Topics: Amides; Animals; Antiviral Agents; Cell Line; Colorimetry; Coloring Agents; Cytidine; Dogs; Guanine; Influenza A virus; L-Lactate Dehydrogenase; Pyrazoles; Ribavirin; Ribonucleosides; Ribose; Tetrazolium Salts; Thiazoles

1995
MTT colorimetric assay system for the screening of anti-orthomyxo- and anti-paramyxoviral agents.
    Journal of virological methods, 1994, Volume: 48, Issue:2-3

    Topics: Amides; Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Colorimetry; Coloring Agents; Cytidine; Dogs; HeLa Cells; Humans; Influenza A virus; Measles virus; Microbial Sensitivity Tests; Orthomyxoviridae; Pyrazoles; Respiratory Syncytial Viruses; Respirovirus; Ribavirin; Ribonucleosides; Ribose; Sensitivity and Specificity; Tetrazolium Salts; Thiazoles; Vero Cells; Virus Replication

1994
Identification of active antiviral compounds against a New York isolate of West Nile virus.
    Antiviral research, 2002, Volume: 55, Issue:1

    Topics: Amides; Animals; Antiviral Agents; Azauridine; Chlorocebus aethiops; Cytidine; Cytopathogenic Effect, Viral; Enzyme Inhibitors; Inhibitory Concentration 50; Mycophenolic Acid; New York; Pyrazoles; Ribavirin; Ribonucleosides; Ribose; Thiouridine; Vero Cells; Virus Replication; West Nile virus

2002
Determination of ribavirin in human serum and plasma by capillary electrophoresis.
    Electrophoresis, 2004, Volume: 25, Issue:10-11

    Topics: Acetonitriles; Chromatography, High Pressure Liquid; Cytidine; Electrophoresis, Capillary; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Ribavirin

2004
Ribavirin antagonizes the in vitro anti-hepatitis C virus activity of 2'-C-methylcytidine, the active component of valopicitabine.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:10

    Topics: Antiviral Agents; Cell Line, Tumor; Cytidine; Drug Antagonism; Drug Therapy, Combination; Hepacivirus; Humans; Ribavirin; Virus Replication

2006
LC-MS/MS method for simultaneous determination of viramidine and ribavirin levels in monkey red blood cells.
    Journal of pharmaceutical and biomedical analysis, 2007, Feb-19, Volume: 43, Issue:3

    Topics: Animals; Antiviral Agents; Calibration; Chromatography, High Pressure Liquid; Cytidine; Erythrocytes; Female; Haplorhini; Male; Mass Spectrometry; Quality Control; Reproducibility of Results; Ribavirin

2007
Combinations of 2'-C-methylcytidine analogues with interferon-alpha2b and triple combination with ribavirin in the hepatitis C virus replicon system.
    Antiviral chemistry & chemotherapy, 2008, Volume: 19, Issue:1

    Topics: Antiviral Agents; Cells, Cultured; Computer Simulation; Cytidine; Deoxycytidine; Drug Synergism; Drug Therapy, Combination; Hepacivirus; Humans; Interferon alpha-2; Interferon-alpha; Models, Chemical; Monte Carlo Method; Polymerase Chain Reaction; Recombinant Proteins; Replicon; Ribavirin; RNA, Ribosomal; RNA, Viral

2008
Potential for hepatitis C virus resistance to nitazoxanide or tizoxanide.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11

    Topics: Antiviral Agents; Cell Line; Cytidine; Drug Resistance, Viral; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Nitro Compounds; Recombinant Proteins; Replicon; Ribavirin; Thiazoles; Virus Replication

2008
Antiviral activity of nucleoside analogues against norovirus.
    Antiviral therapy, 2012, Volume: 17, Issue:6

    Topics: Animals; Antiviral Agents; Cell Line, Tumor; Cytidine; Deoxycytidine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Gastroenteritis; Humans; Lamivudine; Mice; Norovirus; Ribavirin; RNA, Viral; Time Factors; Virus Replication

2012
Inhibition of norovirus replication by the nucleoside analogue 2'-C-methylcytidine.
    Biochemical and biophysical research communications, 2012, Nov-02, Volume: 427, Issue:4

    Topics: Animals; Antiviral Agents; Cell Line; Cytidine; Drug Resistance, Viral; Mice; Norovirus; Ribavirin; Virus Replication

2012
Sensitivity of a ribavirin resistant mutant of hepatitis C virus to other antiviral drugs.
    PloS one, 2013, Volume: 8, Issue:9

    Topics: Amino Acid Substitution; Antiviral Agents; Cell Line; Cytidine; Drug Resistance, Viral; Fluorouracil; Hepacivirus; Hepatitis C, Chronic; Humans; Kinetics; Microbial Sensitivity Tests; Mutation; Ribavirin; Viral Proteins; Virus Replication

2013
In vitro surrogate models to aid in the development of antivirals for the containment of foot-and-mouth disease outbreaks.
    Antiviral research, 2014, Volume: 105

    Topics: Animals; Antiviral Agents; Aphthovirus; Benzimidazoles; Cattle; Cell Line; Chlorocebus aethiops; Cytidine; Cytopathogenic Effect, Viral; Drug Discovery; Foot-and-Mouth Disease; Models, Theoretical; Oximes; Ribavirin; RNA, Viral; Sulfonamides; Virus Cultivation; Virus Replication

2014
Nucleoside analogue 2'-C-methylcytidine inhibits hepatitis E virus replication but antagonizes ribavirin.
    Archives of virology, 2017, Volume: 162, Issue:10

    Topics: Antiviral Agents; Cell Line; Cytidine; Hepatitis E virus; Humans; Ribavirin; Virus Replication

2017
β-d-
    Journal of virology, 2018, 02-01, Volume: 92, Issue:3

    Topics: Alphavirus; Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Cricetinae; Cytidine; Genome, Viral; Humans; Mutation; Ribavirin; Vero Cells; Viral Load; Viral Nonstructural Proteins

2018
Discovery of Pimprinine Alkaloids as Novel Agents against a Plant Virus.
    Journal of agricultural and food chemistry, 2019, Feb-20, Volume: 67, Issue:7

    Topics: Alkaloids; Antiviral Agents; Cytidine; Molecular Structure; Oxazoles; Plant Diseases; Plant Viruses; Ribavirin; Structure-Activity Relationship; Tobacco Mosaic Virus

2019
Effects of the 5'-Triphosphate Metabolites of Ribavirin, Sofosbuvir, Vidarabine, and Molnupiravir on CTP Synthase Catalysis and Filament Formation: Implications for Repurposing Antiviral Agents against SARS-CoV-2.
    ChemMedChem, 2022, 12-05, Volume: 17, Issue:23

    Topics: Antiviral Agents; COVID-19; Cytidine; Escherichia coli; Humans; Ribavirin; SARS-CoV-2; Sofosbuvir; Vidarabine

2022